TNON
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.
Tenon Medical, Inc. (TNON) is rated C+ (2.5/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (A); its weakest is Momentum (F). The rating has held at C+ for 2 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-15 | B- (3.0) | A (4.2) | C (2.3) | F (0.4) | C+ (2.6) | C+ (2.5) |
| 2026-11-08 | B- (3.0) | A (4.2) | C (2.3) | F (0.4) | C+ (2.6) | C+ (2.5) |
| 2026-11-01 | B- (3.0) | A- (4.1) | C (2.4) | F (0.5) | C+ (2.7) | C+ (2.5) |
| 2026-10-25 | B- (3.0) | A- (4.0) | C (2.3) | F (0.4) | C+ (2.6) | C (2.5) |
| 2026-10-18 | B- (3.0) | A- (4.0) | C (2.3) | F (0.5) | C+ (2.6) | C (2.5) |